Current Report Filing (8-k)
June 05 2023 - 4:03PM
Edgar (US Regulatory)
0001851182
false
0001851182
2023-06-01
2023-06-01
0001851182
fhlt:UnitsMember
2023-06-01
2023-06-01
0001851182
us-gaap:CommonStockMember
2023-06-01
2023-06-01
0001851182
fhlt:RedeemableWarrantsMember
2023-06-01
2023-06-01
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event
reported): June 5, 2023 (June 1, 2023)
Future Health ESG Corp.
(Exact name of registrant as specified in its
charter)
Delaware |
|
001-40788 |
|
86-2305680 |
(State
or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(I.R.S.
Employer
Identification No.) |
8 The Green, Suite 12081 |
|
|
Dover, DE |
|
19901 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (833) 388-8734
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
|
¨ |
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of each exchange
on which registered |
Units, each consisting of one share of common stock and one-half of one redeemable warrant |
|
FHLTU |
|
The Nasdaq Stock Market LLC |
Common stock, par value $0.0001 per share |
|
FHLT |
|
The Nasdaq Stock Market LLC |
Redeemable warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share |
|
FHLTW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
Item 3.01 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. |
On June 1, 2023, Future
Health ESG Corp. (the “Company”) received a written notice (the “Notice”) from the listing qualifications department
staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that the Company was not in compliance with Listing Rule
5550(a)(3) (the “Minimum Public Holders Rule”), which requires the Company to have at least 300 public holders for continued
listing on the Nasdaq Capital Market. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect
on the listing or trading of the Company’s securities on the Nasdaq Capital Market.
The Notice states that
the Company has 45 calendar days to submit a plan to regain compliance with the Minimum Public Holders Rule. The Company intends to submit
a plan to regain compliance with the Minimum Public Holders Rule within the required timeframe. If Nasdaq accepts the Company’s
plan, Nasdaq may grant the Company an extension of up to 180 calendar days from the date of the Notice to evidence compliance with the
Minimum Public Holders Rule. If Nasdaq does not accept the Company’s plan, the Company will have the opportunity to appeal the decision
in front of a Nasdaq Hearings Panel.
Forward-looking Statements
The Company makes forward-looking
statements in this report within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements
relate to expectations or forecasts for future events. These statements may be preceded by, followed by or include the words “may,”
“might,” “will,” “will likely result,” “should,” “estimate,” “plan,”
“project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,”
“seek,” “continue,” “target” or similar expressions. These forward-looking statements are based on
information available to the Company as of the date of this report and involve substantial risks and uncertainties. Actual results may
vary materially from those expressed or implied by the forward-looking statements herein due to a variety of factors, including the Company’s
ability to regain compliance with the Minimum Public Holders Rule during any compliance period or in the future or otherwise meet Nasdaq
compliance standards, and other risks and uncertainties set forth in our reports filed with the Securities and Exchange Commission. The
Company does not undertake any obligation to update forward-looking statements as a result of new information, future events or developments
or otherwise.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: June 5, 2023 |
FUTURE HEALTH ESG CORP. |
|
|
|
|
By: |
/s/ Bradley A. Bostic |
|
Name: |
Bradley A. Bostic |
|
Title: |
Chief Executive Officer |
Future Health ESG (NASDAQ:FHLT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Future Health ESG (NASDAQ:FHLT)
Historical Stock Chart
From Aug 2023 to Aug 2024